Sharmila C Mudgal, M.D.,MPH Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: One Orthopedics Drive, Peabody, MA 01960 Phone: 978-539-6200 Fax: 978-539-6199 |
Dr. Leigh Ann Mansberger, MD Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2002 Pheasant Creek Ln, Peabody, MA 01960 Phone: 617-240-5642 |
Lauren Clare Rafka Jansen, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9 Centennial Dr Fl 2, Peabody, MA 01960 Phone: 774-314-8687 |
News Archive
A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication.
Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods and means for treating glomerulonephritis" for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD). Counterparts of the patent have been issued for other territories including the EU, US and China.
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
A letter published today by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.
› Verified 8 days ago